Human aging alters both physiologic function and pharmacologic response. For intravenously-administered hypnotic and opioid drugs used in anesthesia, the rate and extent of drug distribution into tissues control the onset and dissipation of anesthetic effect. our previous research has shown that, as humans age, the distribution of hypnotic drugs (thiopental, etomidate) but not opioids (fentanyl, alfentanil) change. Changes in distribution, in turn, affect the patient's anesthetic dose requirement. This selective influence of age on the distribution of some anesthetic drugs may be caused by a combination of age-related changes in cardiac output, regional blood flow, tissue composition, and drug-solubility in tissues. Our research will determine how age-related changes in body perfusion and tissue size and composition affect the redistribution of thiopental, fentanyl, and alfentanil in the Fl Hybrid rat. These anesthetics were chosen for their clinical relevance, and because their rate and extent of tissue distribution, lipid solubility, and rate of elimination differ markedly in humans and rats. For each drug, four types of studies will be performed in young and old rats. Study 1 will determine dose requirements, plasma pharmacokinetics, and EEG effects. In Study 2, prolonged infusions will estimate steady-state blood:tissue partitioning (solubility). Study 3 will quantitate drug-induced changes in cardiac output and regional blood flow. Study 4 will measure the washout of drug from various tissues over time. The pharmacokinetics of the three drugs in various tissues will be estimated and integrated with the drug-induced changes in regional blood flow. The resulting pharmacokinetic data for individual tissues will be """"""""reassembled"""""""" to create the intact animal, so that detailed computer simulations can then estimate the type and degree of change in cardiac output a regional blood flow necessary to alter anesthetic dose requirement, plasma pharmacokinetics, and EEG response. We will then create this degree of cardiovascular alteration in young Fl Hybrid rats and prospectively estimate the pharmacologic consequences. Our data will provide a scientific basis for determining the appropriate dosage for drugs whose provide a sC pharmacologic effects are terminated by redistribution as age-related changes in cardiovascular function occur. This research will define the degree and extent to which hemodynamic changes associated with aging alter the redistribution of anesthetic drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG004594-10
Application #
3115242
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1984-01-01
Project End
1995-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Bjorkman, S; Wada, D R; Stanski, D R (1998) Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Anesthesiology 88:657-67
Wada, D R; Bjorkman, S; Ebling, W F et al. (1997) Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans. Anesthesiology 87:884-99
Harashima, H; Ebling, W F; Wada, D R et al. (1997) No effect of age on the dose requirement of thiopental in the rat. Exp Gerontol 32:315-24
Wada, D R; Harashima, H; Ebling, W et al. (1996) Effects of thiopental on regional blood flows in the rat. Anesthesiology 84:596-604
MacIver, M B; Mandema, J W; Stanski, D R et al. (1996) Thiopental uncouples hippocampal and cortical synchronized electroencephalographic activity. Anesthesiology 84:1411-24
Wada, D R; Stanski, D R; Ebling, W F (1995) A PC-based graphical simulator for physiological pharmacokinetic models. Comput Methods Programs Biomed 46:245-55
Bjorkman, S; Wada, D R; Stanski, D R et al. (1994) Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models. J Pharmacokinet Biopharm 22:381-410
Burm, A G; Ausems, M E; Spierdijk, J et al. (1993) Pharmacokinetics of alfentanil administered at a variable rate during three types of surgery. Eur J Anaesthesiol 10:241-51
Bjorkman, S; Stanski, D R; Harashima, H et al. (1993) Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model. J Pharmacokinet Biopharm 21:255-79
Verotta, D; Sheiner, L B (1991) Semiparametric analysis of non-steady-state pharmacodynamic data. J Pharmacokinet Biopharm 19:691-712

Showing the most recent 10 out of 28 publications